Zevra Therapeutics Ownership | Who Owns Zevra Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Zevra Therapeutics Ownership Summary


Zevra Therapeutics is owned by 24.39% institutional investors, 6.61% insiders, and 69.01% retail investors. Woodline partners lp is the largest institutional shareholder, holding 8.66% of ZVRA shares.

ZVRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZevra Therapeutics24.39%6.61%69.01%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Woodline partners lp4.14M8.66%$34.52M
Blackrock funding, inc. /de4.08M8.53%$34.03M
Adage capital partners gp3.65M7.63%$30.44M
Vanguard group2.82M5.91%$23.55M
Nantahala capital management2.34M4.90%$19.52M
Fmr2.33M4.87%$19.43M
Altium capital management lp1.85M3.87%$15.43M
683 capital management1.23M2.56%$10.22M
Geode capital management1.19M2.49%$9.91M
State street1.17M2.45%$9.78M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Altium capital management lp1.85M4.38%$15.43M
Stonepine capital management597.70K4.02%$4.98M
Velan capital investment management lp300.00K2.16%$2.50M
Retirement planning co of new england514.83K2.08%$4.29M
Aigh capital management788.61K2.06%$6.58M
Propel bio management179.87K1.49%$1.50M
Nantahala capital management2.34M0.84%$19.52M
Mystic asset management313.35K0.70%$2.61M
683 capital management1.23M0.63%$10.22M
Ikarian capital292.77K0.33%$2.44M

Top Buyers

HolderShares% AssetsChange
Adage capital partners gp3.65M0.05%3.00M
Blackrock funding, inc. /de4.08M0.00%958.66K
Aigh capital management788.61K2.06%788.61K
Rubric capital management lp616.12K0.07%596.12K
State street1.17M0.00%399.73K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management2.34M0.84%-583.69K
Vestal point capital, lp---525.00K
Exoduspoint capital management, lp---386.25K
Silverarc capital management---350.00K
Brandywine global investment management---177.90K

New Positions

HolderShares% AssetsChangeValue
Ikarian capital292.77K0.33%292.77K$2.44M
Boothbay fund management85.82K0.02%85.82K$715.72K
Readystate asset management lp66.66K0.02%66.66K$555.96K
Raymond james financial26.92K0.00%26.92K$224.48K
Entrypoint capital26.45K0.09%26.45K$220.59K

Sold Out

HolderChange
Thompson investment management-1.00
Capital performance advisors llp-40.00
Pnc financial services group-57.00
Steward partners investment advisory-600.00
Stephens consulting-1.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202453-54.31%11,658,947-59.74%240.66%24-63.64%8-55.56%
Sep 30, 202411619.59%28,960,46980.52%604.13%6617.86%1820.00%
Jun 30, 2024975.43%16,043,05615.33%383.45%5660.00%15-57.14%
Mar 31, 2024922.22%13,910,4979.66%332.97%35-27.08%35150.00%
Dec 31, 2023909.76%12,684,98517.55%333.47%4829.73%14-17.65%

Recent Insider Transactions


DateNameRoleActivityValue
Mar 28, 2025Watton Corey Michael-Buy$2.35K
Mar 19, 2025Bode John B-Buy$79.62K
Feb 13, 2025Sangiovanni Timothy J. SVP, Finance & Corp ControllerSell$23.59K
Feb 13, 2025Schafer Joshua CCO & EVP, Bus. DevelopmentSell$82.53K
Feb 13, 2025Clifton R. LaDuane CFO & TreasurerSell$86.47K

Insider Transactions Trends


DateBuySell
2025 Q115
2024 Q41-
2024 Q33-
2024 Q2--
2024 Q1--

ZVRA Ownership FAQ


Who Owns Zevra Therapeutics?

Zevra Therapeutics shareholders are primarily institutional investors at 24.39%, followed by 6.61% insiders and 69.00% retail investors. The average institutional ownership in Zevra Therapeutics's industry, Biotech Stocks , is 68.48%, which Zevra Therapeutics falls below.

Who owns the most shares of Zevra Therapeutics?

Zevra Therapeutics’s largest shareholders are Woodline partners lp (4.14M shares, 8.66%), Blackrock funding, inc. /de (4.08M shares, 8.53%), and Adage capital partners gp (3.65M shares, 7.63%). Together, they hold 24.83% of Zevra Therapeutics’s total shares outstanding.

Does Blackrock own Zevra Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Zevra Therapeutics.

Who is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Zevra Therapeutics’s biggest shareholder by percentage of total assets invested, with 4.38% of its assets in 1.85M Zevra Therapeutics shares, valued at 15.43M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools